|

Pembrolizumab and Lenvatinib Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 2

Top Sponsors

  • University College, London1
  • Peking Union Medical College Hospital1

Indications

  • Cancer2
  • Liver Disease1
  • Biliary Tract Neoplasms Immunotherapy1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other2 trials

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
Phase 2
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.